DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02480 LUZHU BIOTECH-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders KONG Jian & Associates (47.20%)
Biological Medicine Investment Center (Limited Partnership) (9.88%)
Beijing Yizhuang II Biological Medical Industry Investment Fund (9.21%)
Beijing Science Sun Pharmaceutical Co., Ltd. (6.91%)
[00939] China Construction Bank Corporation (5.71%)		 Sector Health Care & Biotechnology
Web Site http://www.luzhubiotech.com Tel (86 010) 6156-8561
Email IR@luzhubiotech.com Fax (86 010) 6156-7093
Related Equities N/A
Principal Activities Principally engaged in research, development and production of vaccines and therapeutic biologics in the PRC.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top